As we step into a new era of medical innovation, it's crucial to shine a light on diseases that have long remained in the shadows. Amyotrophic lateral sclerosis...
Continue reading
Families affected by ALS urged to join free program to uncover their genetic risk, contribute to research, and access new therapies Sano Genetics launches ‘Ligh...
Continue reading
ALS remains one of the most challenging neurodegenerative diseases, with limited treatment options and a progressive course that affects motor function, breathi...
Continue reading
Metabolic dysfunction-associated steatohepatitis (MASH), previously known as nonalcoholic steatohepatitis (NASH), is a complex liver disease characterized by fa...
Continue reading
This webinar, hosted by Sano CEO Dr. Patrick Short and featuring David Ochoa, Platform Coordinator at Open Targets, explores the significance of human genetics ...
Continue reading
As precision medicine trials increasingly depend on genetic eligibility criteria, the process of testing, interpreting results, and guiding patients through the...
Continue reading
Genetic testing has become a defining capability in biotechnology and pharmaceutical development. By revealing the specific genetic variants that influence dise...
Continue reading
While lifestyle choices and environment can impact risk, genes are often what most affect how likely a person is to develop a disease. People commonly have diff...
Continue reading
CRISPR (clustered regularly interspaced short palindromic repeats) and CRISPR-associated (Cas) proteins were first characterized as part of bacterial immune def...
Continue reading
Pharmacogenomics, also known as pharmacogenetics, is a field of research dedicated to investigating how an individual's genetic makeup influences their response...
Continue reading